BA.5 is pummeling Jewish summer camps, sickening campers, canceling visiting days

With the coronavirus spreading rampantly among campers and staff, summer camps have rejiggered their plans.

By Jackie Hajdenberg/JTA

Researchers create COVID-19 antibodies from eggs - study

Researchers say that birds are ideal for producing antibodies quickly and cheaply, and these could potentially be used to treat or help prevent COVID-19.

Pfizer CEO Dr. Albert Bourla - Jewish COVID-19 hero

Genesis Prize Deputy CEO Sana Britavsky: “Albert himself is a humble man, but also a remarkable Jewish phenomenon.”


World population to reach 8 billion this year - UN

Still, the UN warns that populations are decreasing worldwide • by 2050, senior citizens will outnumber children for the first time in world history • Guterres: "our world is in peril"

Moderna: New booster protects better against variants

Moderna said it is simultaneously developing an additional vaccine adapted to Omicron and based on BA.4/5, in accordance with the latest FDA guidelines

Ukrainian refugees: Host states need to look out for health issues - study

At least 12 million Ukrainians have fled their homes since the war began. Of these, over six million have left Ukraine itself for other countries.

Biden won't be shaking hands in Israel due to COVID surge

The White House has reportedly told Prime Minister Yair Lapid’s office that due to the surge in COVID-19 infections in the US and Israel, the president will refrain from shaking hands.

Blood cancer patients gain COVID-19 antibodies if given vaccine booster - study

Blood cancer patients, already at high risk, often did not develop antibodies against COVID-19 from the first shot. But the booster and antibody therapy can provide a better shield.


Middle Eastern children more likely to develop this COVID-19 complication

MIS-C is a rare condition that is characterized by intense inflammation that can affect multiple organs including the heart, lungs, kidney, brains, skin, eyes, and gastrointestinal organs.

4th COVID-19 vaccine effective in protecting elderly against Omicron - study

Elderly recipients of the fourth dose of the vaccine were observed to be 67% less likely to be hospitalized than those who got the third dose.

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy